<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02109237</url>
  </required_header>
  <id_info>
    <org_study_id>HREC/13/QPCH/217</org_study_id>
    <nct_id>NCT02109237</nct_id>
  </id_info>
  <brief_title>Sleep Disorders in Bronchiolitis Obliterans Syndrome 2&amp;3</brief_title>
  <official_title>The Prevalence and Treatment of Sleep Disorders in Lung Transplant Recipients With BOS 2 &amp; 3 and the Influence on Quality of Life and Daytime Activity.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Prince Charles Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Prince Charles Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is to determine whether sleep disorders contribute to impaired quality of life and
      mobility in patients with Bronchiolitis Obliterans syndrome and whether non invasive positive
      airways pressure ventilation can improve sleep, quality of life and mobility in this patient
      group.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients with Bronchiolitis Obliterans syndrome (BOS) 2 &amp; 3 (25) will be matched 1:2 BOS 0
      patients with similar demographics such as age, gender, BMI, time post transplant and renal
      dysfunction.Patients fitting inclusion/exclusion criteria once they have given informed
      consent will complete questionnaires on quality of life (QOL), any sleep issues they may have
      and be assessed by a doctor. Data from standard blood tests, respiratory function tests and
      physio assessments of daytime activity, mobility and muscle strength will be collected. All
      participants will undergo an overnight sleep study. If a sleep disorder is identified the
      participant will be offered appropriate treatment. All assessments with the exception of the
      sleep study will be repeated at 6 and 12 months post sleep study.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">September 2019</completion_date>
  <primary_completion_date type="Anticipated">September 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>To Measure Prevalence of sleep disorders in Bronchiolitis Obliterans 2&amp;3 patients</measure>
    <time_frame>12 months</time_frame>
    <description>Using level one laboratory based polysomnograph</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quality of life assessment using Rand SF36 standard survey</measure>
    <time_frame>Baseline, 6 and 12 months after sleep study</time_frame>
    <description>Participants will complete Rand SF36 standard survey for Quality of life. This will be completed at baseline visit and at 6 and 12 months post sleep study</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Assessment of daytime activity, mobility and muscle strength</measure>
    <time_frame>Baseline, 6 and 12 months post sleep study</time_frame>
    <description>As part of standard care transplant patients are assessed for daytime activity, mobility and muscle strength every 6months this data will be used to assess any changes post treatment for sleep disorders</description>
  </other_outcome>
  <other_outcome>
    <measure>Lung function assessment</measure>
    <time_frame>Baseline, 6 and 12 months post sleep study</time_frame>
    <description>Assessment of lung function to determine any variation post treatment for sleep disorder.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">75</enrollment>
  <condition>Bronchiolitis Obliterans</condition>
  <condition>Sleep Disordered Breathing Central</condition>
  <arm_group>
    <arm_group_label>Bronchiolitis Obliterans 2 &amp; 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Assessment of sleep disorders and treatment if required</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Bronchiolitis Obliterans 0</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Assessment of sleep disorders and treatment if required</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Assessment of sleep disorders and treatment if required</intervention_name>
    <description>Assessment of sleep disorders and treatment if required</description>
    <arm_group_label>Bronchiolitis Obliterans 2 &amp; 3</arm_group_label>
    <arm_group_label>Bronchiolitis Obliterans 0</arm_group_label>
    <other_name>Level 1 polysomnograpgh assessment and treatment if required</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients who are post lung, heart lung and heart lung liver transplant with
             bronchiolitis obliterans 2 &amp; 3

          -  Comparative group -Patients who are post lung, heart lung and heart lung liver
             transplant with bronchiolitis obliterans 0

          -  Identified possible sleep related disorder

        Exclusion Criteria:

          -  Subjects who do not provide informed consent

          -  Subjects unable to understand the study and related procedures

          -  Patients with a life expectancy of less than 6 months
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andreas Fiene, BA Med,Surg. FRACP MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Prince Charles Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James Douglas, MBBS FRACP MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>The Prince Charles Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>The Prince Charles Hospital</name>
      <address>
        <city>Brisbane</city>
        <state>Queensland</state>
        <zip>4032</zip>
        <country>Australia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Andreas Fiene, BA Med, Surg FRACP MD</last_name>
      <phone>+61 07 31394000</phone>
      <email>andreas.fiene@health.qld.gov.au</email>
    </contact>
    <contact_backup>
      <last_name>James Douglas, MBBS FRACP MD</last_name>
      <phone>+61 07 3139 4000</phone>
      <email>james.douglas@health.qld.gov.au</email>
    </contact_backup>
    <investigator>
      <last_name>Andreas Fiene, BA Med Surg FRACP MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>James Douglas, MBBS FRACP MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Australia</country>
  </location_countries>
  <verification_date>May 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 7, 2014</study_first_submitted>
  <study_first_submitted_qc>April 8, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 9, 2014</study_first_posted>
  <last_update_submitted>May 1, 2017</last_update_submitted>
  <last_update_submitted_qc>May 1, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">May 3, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Prince Charles Hospital</investigator_affiliation>
    <investigator_full_name>Anne Carle</investigator_full_name>
    <investigator_title>Dr A. Fiene &amp; Dr J Douglas</investigator_title>
  </responsible_party>
  <keyword>Lung transplantation</keyword>
  <keyword>Bronchiolitis obliterans</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
    <mesh_term>Sleep Wake Disorders</mesh_term>
    <mesh_term>Parasomnias</mesh_term>
    <mesh_term>Bronchiolitis Obliterans</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

